Somatoform disorders;Somatoforme stoornisen

Tijdschrift voor Psychiatrie

Volumn 43, Issue 2, 2001, Pages 83-93

  Van Houdenhove, B ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Functional somatic syndromes; Psychosomatics; Somatization; Somatoform disorders; Unexplained somatic symptoms

Indexed keywords

ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL PRACTICE; COGNITION; DISEASE CLASSIFICATION; HUMAN; HYPOCHONDRIASIS; NEUROSIS; PSYCHODYNAMICS; PSYCHOSOMATIC DISORDER; PSYCHOTHERAPY; SOCIAL PSYCHOLOGY;

EID: 0035135782     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (116)

1. Omgaan met somatiseren bij patiënten met borderline persoonlijkheidsstoornis: Een netwerkbenadering
2. The meaning of psychological symptoms: Effectiveness of group interventions with hypochondriacal patients
3. Amplification, somatization, and the somatoform disorders
4. Somatization and medicalization in the era of managed care
5. A comprehensive approach to the chronically somatizing patient
6. Review. Functional somatic syndromes
7. Somatoform disorders and personality disorders: Syndromal comorbidity and overlapping development pathways
8. Early life stress, negative paternal relationships, and chemical intolerance in middle-aged women: Support for a neural sensitization model
9. Motor conversion disorders: A prospective 2- to 5-year follow-up study
10. Hypochondrie: Angst voor ernstige ziekten
11. Somatic presentation of DSM-III psychiatric disorders in primary care
12. Onbegrepen lichamelijke klachten. Voorlichting biedt perspectief
13. In-patient treatment for chronic fatigue syndrome
14. Two psychological treatments for hypochondriasis
15. Techniques for interviewing the somatizing patient
16. Slater revisited: 6-Year follow-up of patients with medically unexplained motor symptoms
17. Childhood abuse, personality disorder and chronic fatigue syndrome/fibromyalgia
18. 'Wheelchair' patients with nonorganic disease: A psychological inquiry
19. A randomised controlled trial of cognitive behavioral versus relaxation therapy for chronic fatigue syndrome
20. A taxonomy of medically unexplained symptoms
21. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome
22. Presidential address: Gastrointestinal illness and the biopsychosocial model
23. Cognitive-behavioral group therapy for irritable bowel syndrome: Effects and long-term follow-up
24. Towards effective reassurance in irritable bowel syndrome: The importance of attending to patients' complaint-related cognitions
25. Somatization in the community
26. Abridged somatization: A study in primary care
27. DSM-IV somatoform disorders: Do we need a new classification?
28. Fluoxetine for hypochondriacal patients without major depression
29. The pharmacotherapy of hypochondriasis
30. Hypochondriasis vs. anxiety disorders. Why should we care?
31. Somatization - Beyond symptom count
32. Somatization in primary care. Prevalence, health care utilization, and general practitioner recognition
33. Somatization and fashionable diagnoses. Illness as a way of life
34. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome
35. Somatization in children
36. Frequent consulters in general practice: A systematic review of studies of prevalence, associations and outcome
37. Somatization in cross-cultural perspective: A World Health Organization study in primary care
38. The validity and significance of the clinical diagnosis of hysteria (Briquet syndrome)
39. Imaging hypnotic paralysis: Implications for conversion hysteria
40. Childhood risk factors for adults with medically unexplained symptoms: Results from a national birth cohort study
41. Psychosomatische revalidatie: Leren omgaan met chronische vermoeidheid en pijn
42. Enhancing the health of somatization disorder patients. Effectiveness of short-term group therapy
43. Current concepts of somatization
44. Culture and somatization: Clinical, epidemiological, and ethnographic perspectives
45. A comparative study of iatrogenesis, medication abuse, and psychiatric morbidity in chronic pain patients with and without medically unexplained symptoms
46. Multisomatoform disorder: An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care
47. A symptom checklist to screen for somatoform disorders in primary care
48. The role of corticotropin releasing factor in pain and analgesia
49. Chronische pijn en de familie
50. Group therapy for somatization disorders in general practice: Effectiveness of a short cognitive-behavioural treatment model
51. Somatization: The concept and its clinical application
52. The psychobiology of hysteria
53. The cognitive-behavioral model of hypochondriasis: Misinformation and triggers
54. The somatoform conundrum: A question of nosological values
55. Clinical characteristics of women with a history of childhood abuse
56. Somatic fixation in patients and physicians: A biopsychosocial approach
57. Pain and stress: A new perspective
58. Klinische behandeling van zestien patiënten met een motorische conversiestoornis: Een "pilot-studie"
59. Systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy and behavior therapy for chronic pain in adults, excluding headache
60. The development and psychometric characteristics of the somatoform dissociation questionnaire (SDQ:20)
61. Effect of cognitive-behavior therapy on persons with body dysmorphic disorder and comorbid axis ii diagnosis
62. Health attitude survey. A scale for assessing somatizing patients
63. Correlates of hypochondriasis in a nonclinical population
64. The antidepressant induced analgesic effect
65. Rethinking somatoform disorders
66. Effects of attention training on hypochondriasis: A brief case series
67. Cognitive-behavioral therapy for non-cardiac chest pain: A randomized trial
68. Understanding medically unexplained physical symptoms: Faster progress in the next century than in this?
69. Body dysmorphic disorder: Diagnosis and treatment of imagined ugliness
70. Efficacy of fluvoxamine in body dysmorphic disorder
71. Gender and cross-cultural differences in somatic symptoms associated with emotional distress. A study in primary care
72. A troubled youth: Relations with somatization, depression, and anxiety in adulthood
73. Nosologomanie, een aandoening van de psychiatrie
74. Briquet's syndrome, dissociation and abuse
75. Somatoform disorders
76. The association of sexual and physical abuse with somatization: Characteristics of patients presenting with irritable bowel syndrome and non-epileptic attack disorder
77. The classification of multiple somatoform symptoms
78. Somatization: Future perspectives on a common phenomenon
79. Elevated levels of psychophysiological arousal and cortisol in patients with somatization syndrome
80. Toward empirically based criteria for the classification of somatoform disorders
81. From gut to brain and back - A new perspective into functional gastrointestinal disorders
82. Latent variable models of functional distress
83. Wat is somatiseren?
84. Pathophysiological mechanisms of somatization
85. Inpatient treatment of persistent somatization
86. A follow-up of patients diagnosed as suffering from 'hysteria'
87. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somatizing patients
88. Cognitive behavioural therapy for medically unexplained physical symptoms: A randomised controlled trial
89. De kunst van het geruststellen
90. Dissociative experiences and psychopathology in conversion disorder
91. Attachment and interpersonal communication in somatization
92. A psychodynamic view on the chronic fatigue syndrome
93. Somatization in primary care
94. A developmental perspective on family risk factors in somatization
95. Customizing treatment for chronic pain patients: Who, what, and why
96. Long-term out-come of hypochondriacal personality disorder
97. Sensitization, somatization, and subjective health complaints
98. A controlled trial of cognitive-behavioral treatment of hypochondriasis
99. Health complaints, stress and distress: Exploring the central role of negative affectivity
100. A double blind, placebo-controlled trial of fluoxetine and a graded exercise programme for chronic fatigue syndrome
101. Functional somatic syndromes: One or many?
102. Modelling and reinforcement of the sick role during childhood predicts adult illness behavior